home / stock / y / y news


Y News and Press, Alleghany Corporation From 08/10/21

Stock Information

Company Name: Alleghany Corporation
Stock Symbol: Y
Market: NYSE
Website: alleghany.com

Menu

Y Y Quote Y Short Y News Y Articles Y Message Board
Get Y Alerts

News, Short Squeeze, Breakout and More Instantly...

Y - Alleghany Announces Pricing Of $500 Million Of 3.250% Senior Notes Due 2051

Alleghany Announces Pricing Of $500 Million Of 3.250% Senior Notes Due 2051 PR Newswire NEW YORK , Aug. 10, 2021 /PRNewswire/ -- Alleghany Corporation ("Alleghany") (NYSE-Y) today announced that it has priced its public offering of $500 million of 3.250%...

Y - Alleghany EPS beats by $1.74

Alleghany (NYSE:Y): Q2 Non-GAAP EPS of $17.39 beats by $1.74; GAAP EPS of $29.00. Revenue of $2.93B (+31.4% Y/Y) Press Release For further details see: Alleghany EPS beats by $1.74

Y - Alleghany Corporation Reports 2021 Second Quarter -- Notice

Alleghany Corporation Reports 2021 Second Quarter -- Notice PR Newswire NEW YORK , Aug. 5, 2021 /PRNewswire/ -- Alleghany Corporation (NYSE:Y) today announced its financial results for the second quarter ended June 30 , 2021.  A complete, full-text news ...

Y - 4 Property and Casualty Insurance Stocks to Add to Your Portfolio

The U.S. property and casualty insurance market experienced a mixed impact from the pandemic, with high underwriting profitability offsetting weakened premium volume. But because 2021 is expected to be the fourth consecutive year of underwriting profit for the industry, we think it could be w...

Y - Alleghany Corporation to Announce 2021 Second Quarter Results on August 5, 2021

Alleghany Corporation to Announce 2021 Second Quarter Results on August 5, 2021 PR Newswire NEW YORK , July 9, 2021 /PRNewswire/ -- Alleghany Corporation (NYSE:Y) today announced that it will release its financial results for the second quarter of 2021 after...

Y - Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan

Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) today announced submission of a New Drug Application (NDA) for its new anti-cancer drug darinaparsin (generic name, development code: SP-02) as a treatment...

Y - Nikola and Hyliion among industrial companies to join Russell 3000 Index; while Wrap Technologies and Orion Energy Systems to leave

At 2021 Russell indexes annual reconstitution, following industrials stocks will be added to and deleted from the Russell 3000 Index.Additions include: Desktop Metal (DM), Donnelley (RRD), Hyliion (HYLN), Ideanomics (IDEX), Nikola (NKLA), Paysafe (PSFE), ...

Y - Alleghany says Berkshire Hathaway's General Re won't renew underwriting pact

Alleghany Corp. ([[Y]] +0.1%) discloses that Berkshire Hathaway's ([[BRK.B]] -0.2%) ([[BRK.A]] +0.3%) General Re subsidiary won't extend its underwriting agreement with Alleghany's Transatlantic Reinsurance unit.In July 2016, Transatlantic Re and General Re entered into a five-year agreement ...

Y - Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth

Olympus Corporation (”Olympus” – Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company Medi-Tate Ltd. (“Medi-Tate” – CEO: Ido Kilemnik...

Y - IVOV: Midcap Value ETF Review

IVOV strategy and facts. Comparing IVOV with my value model. Two strategy issues. For further details see: IVOV: Midcap Value ETF Review

Previous 10 Next 10